U.S. market Closed. Opens in 11 hours 40 minutes

PTIXW | Protagenic Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-06-302014-06-302013-06-302010-12-312009-12-312008-12-312007-12-312006-12-312006-07-312005-07-312004-07-312002-07-312001-07-312000-07-311999-07-311998-07-311997-07-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A85.00K40.03M69.09M113.88M36.98M18.72MN/AN/AN/A18.57M21.63M21.39M18.76M15.62M12.57M
Cost of Revenue28.22K30.00N/A286.00339.00N/AN/AN/AN/AN/AN/A42.71M53.87M84.29M5.01M597.00KN/AN/AN/A10.55M12.27M11.78M10.96M7.80M6.74M
Gross Profit-28.22K-30.00N/A-286.00-339.00N/AN/AN/AN/AN/A85.00K-2.68M15.22M29.59M31.97M18.12MN/AN/AN/A8.03M9.36M9.60M7.80M7.81M5.83M
Operating Expenses4.50M3.56M4.14M2.55M2.09M2.31M2.37M1.83M491.00K975.00K758.00K14.77M26.79M31.90M37.47M16.65M70.58K94.47KN/A8.55M8.61M7.77M8.08M6.95M6.50M
Selling, General & Admin1.18M1.97M3.00M1.85M1.28M1.43M1.65M1.41M491.00K975.00K758.00K13.12M23.09M26.03M37.47M16.65M70.58K94.47KN/A8.55M8.61M7.77M8.08M6.95M6.50M
Research & Development3.32M1.59M1.14M699.80K807.95K881.19K717.45K417.87KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.64M3.70M5.87MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-4.53M-3.56M-4.14M-2.55M-2.09M-2.31M-2.37M-2.23M-491.00K-975.00K-673.00K-17.45M-11.57M-2.31M-5.50M1.47M-70.58K-94.47KN/A-528.00K747.00K1.83M-275.00K866.00K-661.00K
Other Expenses / Income-473.53K2.28K-382.52K2.88K335.22K-246.19K91.80K-42.33K-10.00K51.00K-133.00K-3.17M-17.29M-114.33M430.00K-89.00K-10.33KN/A-1.33M-306.00K-440.00K-496.00KN/AN/AN/A
Before Tax Income-5.00M-3.56M-4.52M-2.55M-1.75M-2.56M-2.26M-2.28M-501.00K-924.00K-806.00K-20.61M-28.86M-116.64M-5.07M1.39M-80.91KN/A-1.33M-834.00K307.00K1.34MN/AN/AN/A
Income Tax Expenses2.0046.05K463.70K246.18K15.89K486.81KN/AN/AN/AN/AN/A-1.07M640.00K-852.00K-1.20M708.00K-3.25KN/AN/A-106.00K163.00K203.00KN/AN/AN/A
Net Income-5.00M-3.60M-4.99M-2.79M-1.77M-2.56M-2.26M-2.28M-476.00K-1.08M-1.03M-19.73M-29.47M-115.77M-4.15M677.00K-77.67K-94.47K-2.23M-728.00K144.00K1.14M-674.00K648.00K-858.00K
Interest Expenses-107.68K137.46K496.91K246.18K15.89K2.79KN/A7.16K18.00K3.00KN/A16.00K76.00K147.00K22.00K14.00K10.33KN/AN/A306.00K440.00K496.00KN/AN/A197.00K
Basic Shares Outstanding4.34M4.32M3.69M2.58M2.57M2.57MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Diluted Shares Outstanding4.34M4.32M3.69M2.58M2.57M2.57MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBITDA-4.50M-3.37M-4.11M-2.55M-2.08M-2.07M-2.26M-1.83M-490.00K-975.00K-1.03M-19.13M-25.06M-110.60M-3.98M1.42M-70.58K-94.47KN/A1.57M2.77M3.73M1.24M2.20M462.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,208.24%-47.80%-36.27%-97.12%-10.76%7.61%0.00%0.00%0.00%8.43%12.83%17.42%6.60%14.06%3.67%
EBIT-5.11M-3.42M-4.03M-2.30M-1.74M-2.07M-2.26M-2.27M-458.00K-1.08M-1.03M-20.78M-28.75M-116.47M-5.33M1.40M-70.58K-94.47K-2.23M-528.00K747.00K1.83M-674.00K648.00K-661.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,208.24%-51.91%-41.62%-102.27%-14.41%7.47%0.00%0.00%0.00%-2.84%3.45%8.58%-3.59%4.15%-5.26%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-06-302014-06-302013-06-302010-12-312009-12-312008-12-312007-12-312006-12-312006-07-312005-07-312004-07-312002-07-312001-07-312000-07-311999-07-311998-07-311997-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙